A novel class of pyrrolidinyl-acetyleneic thieno[3,2-d]pyrimidines has been identified which potently inhibit the EGFR and ErbB-2 receptor tyrosine kinases. Synthetic modifications of the pyrrolidine carbamate moiety result in a range of effects on enzyme and cellular potency. In addition, the impact of the absolute stereochemical configuration on cellular potency and oral mouse pharmacokinetics is described.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2008.11.023 | DOI Listing |
Publication Analysis
Top Keywords
egfr erbb-2
8
cellular potency
8
synthesis stereochemical
4
stereochemical effects
4
effects pyrrolidinyl-acetylenic
4
pyrrolidinyl-acetylenic thieno[32-d]pyrimidines
4
thieno[32-d]pyrimidines egfr
4
erbb-2 inhibitors
4
inhibitors novel
4
novel class
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!